A breakthrough pancreatic cancer drug won approval. They still struggle to access it

When the Food and Drug Administration approved a new pancreatic cancer drug called Rasonque last month, researchers and patient advocates celebrated. Kelsey Solano felt a pit in her stomach. 

“Only because the expanded access program immediately closed,” Solano recalled.

Read the rest…